ABSTRACT Examination of the sequences of the first complementarity-determining segments of the light chains of two IgM cold agglutinins against blood group I, four monoclonal IgM antibodies against IgG proteins, and of three Bence Jones proteins provides clues for predicting which residues contribute to antibody specificity and indicates that these predictions may be tested by evaluating recovery of antibody activity and specificity when various light chains are recombined with homologous and heterologous heavy chains. The verification, by x-ray crystallographic studies of Fab' fragments (1, 2) , Bence Jones proteins (3, 4) , and Fv fragments (5, 6 ) (see also ref. 7) and by affinity labeling (8) , of the prediction (9, 10) that the hypervariable regions are the complementarity-determining segments and form the antibodycombining site has substantially simplified the problem of understanding the nature of immunological specificity (11) . Thus, the noncomplementarity-determining segments of the light chain of the variable region (VL) and the heavy chain of the variable region (VH) form a three-dimensional framework of twisted fl-sheets so oriented spatially as to position the complementarity-determining segments at the tip of the molecule available for reacting with the antigenic determinant (1-7). It becomes possible therefore to correlate antibody specificity with sequence data on the complementarity-determining segments as such data become available and also to predict structures of other combining sites by inserting sequences of complementarity-determining segments when these have been determined for antibodies of known specificities. Thus, using the structure of the Fab' fragment of the phosphocholine-binding myeloma protein McPC603 (2, 7), a model was constructed of a combining site for an antibody to the type III capsular polysaccharide of the pneumococcus (12) and for an antibody site complementary to 2,4-dinitrophenyl (13) ; the validity of these models may ultimately be decided by x-ray crystallography.
As more sequence data become available, the role of individual residues in antibody-combining sites may be evaluated. By use of a data bank (14) of variable region sequences aligned for maximum homology and stored in the PROPHET computer system (15), a statistical analysis of the occurrence in complementarity-determining segments of pairs of residues more frequently than expected by chance permitted the recognition of two contacting residues Tyr 33 and Glu 35 in the first complementarity-determining segment of the heavy chain of phosphocholine-binding mouse myeloma proteins, the assignment of a structural role to Met 34, and the recognition of the probable contribution of Phe 32 to the orientation of Tyr 33 (16) . The sequence Phe-Tyr-Met-Glu has not been found in any other protein tabulated (14, (17) (18) (19) (35) .
Two additional proteins, IKE and TAK, differ from DRE, GLO, and SIE at position 30, assuming position 27 of TAK to be Gln (footnotea , Table 1 ). IKE, a Bence Jones protein without known antibody specificity, has Asn instead of Ser, while in TAK, another IgM cold agglutinin with anti-I specificity, the residue has not been identified but is either Gly or Trp (28). Three proteins TI, WIL, and POM differ from DRE, GLO, and SIE by two amino acid residues. The first two are Bence Jones proteins without known antibody activity having Asn at position 30 like IKE but having Phe and Met, respectively, at position 32. The third POM, an IgM with anti-IgGl specificity (31) , differs in idiotypic specificity from GLO and SIE and has Ile at position 28 instead of Val and Asn at position 30.
The last protein, LAY, has a VjT light chain, belongs to the Po group in idiotypic specificity, and is an IgM but differs from POM in showing both anti-IgG1 and anti-IgG3 specificity (31, 35) .
These data permit certain testable predictions to be made. (i) The complete sequences of the variable regions of both chains of LAY and POM, as established by Klapper and Capra (25) have shown that the heavy chains each have identical second and third complementarity-determining segments and that the light chains are identical in their third and in residues 50 through 54 of their second complementarity-determining segment but differ at positions 55 and 56, which were considered (9) as part of the second complementarity-determining segment. LAY and POM differ by only one residue in the first complementarity-determining segment of their heavy chains having Ala and Ser, respectively, at position 31; the first complementarity-determining segments of their light chains differ at six positions (Table 1) and, in addition, that of LAY is one residue shorter.
Since these are the only differences in complementaritydetermining segments, they must be responsible for the difference in specificity, LAY reacting equally well with IgGl and IgG3 while POM is more specific for IgGl. Moreover, since their heavy chains differ by only one residue, the bulk of the specificity difference probably resides in their light chains.
Chain recombinations with these two proteins to evaluate the effects of antibody specificity would be of interest.
(ii) The three Bence Jones proteins IKE, TI, and WIL most probably do not come from Waldenstrom IgM with anti-IgG activity or from cold agglutinins with anti-I specificity since light chains from such proteins almost never occur in urine as Bence Jones proteins. Thus the finding that TI and WIL differ at positions 28 and 32 and that IKE differs only at position 28 from POM implicates the Ile at position 28 as an important contacting residue of the anti-IgGl site, with this position and the substitutions at other positions in LAY making for the differences in specificity. The effect of recombining the heavy chains of LAY and POM with the three Bence Jones proteins on antibody and idiotypic specificity would also contribute insights into the role of various residues on specificity.
These sequences may also be correlated with the x-ray structure of protein REI, a VJT Bence Jones protein dimer with one less residue in the first complementarity-determining segment than all of the chains in Table 1 
